Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and reducing racial and ethnic disparities in mental health care.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, originally funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. The MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues have conducted several large studies across MHRN health systems, including:
Dr. Simon sits on the editorial board for the journal General Hospital Psychiatry, and co-chairs the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation.. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990. He is also a professor in the department of Health Systems Science at the Bernard J Tyson Kaiser Permanente School of Medicine and an adjunct professor inPsychiatry and Behavioral Dciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Tiemens BG, Ormel J, Simon GE. Occurrence, recognition, and outcome of psychological disorders in primary care. Am J Psychiatry. 1996;153(5):636-44. PubMed
Von Korff M, Ustun TB, Ormel J, Kaplan I, Simon GE. Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol. 1996;49(3):297-303. PubMed
Simon GE, Grothaus L, Durham ML, VonKorff M, Pabiniak C. Impact of visit copayments on outpatient mental health utilization by members of a health maintenance organization. Am J Psychiatry. 1996;153(3):331-8. PubMed
Simon G, Von Korff M. Delivery of services to mood disordered patients. Curr Opin Psychiatry. 1996;9:30-4. PubMed
Katon W, Ludman E, Simon G, Lin E, Sullivan M, Walker E, Bush T, Von Korff M, Carter L. Depression: a self-care companion. New York: Patient Education Media, Inc., 1996. PubMed
Ludman EJ, Katon W, Bush T, Von Korff M, Lin E, Simon G, Walker E, Unutzer J. Design and methodology of a multimodal primary care-based brief intervention to prevent depression relapse. International Journal of Psychiatry in Medicine,. 1996. PubMed
Simon GE, Lecribier Y, Ustun TB. Somatic symptoms and psychiatric disorder: an international primary care study. Reviews in Contemporary Pharmacotherapy. 1996;7:279-285. PubMed
Simon GE, Lin EH, Katon W, Saunders K, VonKorff M, Walker E, Bush T, Robinson P. Outcomes of "inadequate" antidepressant treatment. J Gen Intern Med. 1995;10(12):663-70. PubMed
Simon GE, Maier W, Ustun TB, Linden M, Boyer P. Research diagnosis of current depressive disorder: a comparison of methods using current symptoms and lifetime history. J Psychiatr Res. 1995;29(6):457-65. PubMed
Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52(10):850-6. PubMed
In a new multistate study, the Zero Suicide Model reduced suicide rates by 25%.
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.